Landos Biopharma, Inc. Human Resources Contracts & Agreements
9 Contracts & Agreements
- Bonus & Incentive Agreements (1 contract)
- Compensation Agreements (1)
- Employment Agreements (4)
- Separation Agreements (2)
- Severance Agreements (1)
- Severance Agreement by and between the Company and Fabio Cataldi, effective as of September 5, 2022 (Filed With SEC on May 12, 2023)
- Employment Agreement by and between the Company and Gregory Oakes, effective as of June 20, 2022 (Filed With SEC on August 11, 2022)
- Separation and Release of Claims Agreement by and between the Company and Jyoti Chauhan, dated May 4, 2022 (Filed With SEC on August 11, 2022)
- Employment Agreement by and between the Company and Patricia L. Bitar, effective as of December 17, 2021 (Filed With SEC on March 24, 2022)
- Employment Agreement by and between the Company and Tim M. Mayleben, effective as of December 17, 2021 (Filed With SEC on March 24, 2022)
- Separation and Release of Claims Agreement by and between the Company and Josep Bassaganya-Riera, dated November 6, 2021 (Filed With SEC on March 24, 2022)
- Non-Employee Director Compensation Policy (Filed With SEC on March 31, 2021)
- 2019 Equity Incentive Plan, as amended (Filed With SEC on January 28, 2021)
- Employment Agreement by and between the Registrant and Dr. Josep Bassaganya-Riera, effective as of January 1, 2020 (Filed With SEC on January 13, 2021)
